title: Progress towards a genome-derived, epitope-driven vaccine for latent TB infection.
authors.affiliation: EpiVax, Inc, Providence, RI, USA.
authors.forename: Leonard
authors.initials: L
authors.lastname: Moise
authors.forename: Julie
authors.initials: J
authors.lastname: McMurry
authors.forename: Daniel S
authors.initials: DS
authors.lastname: Rivera
authors.forename: E Jane
authors.initials: EJ
authors.lastname: Carter
authors.forename: Jinhee
authors.initials: J
authors.lastname: Lee
authors.forename: Hardy
authors.initials: H
authors.lastname: Kornfeld
authors.forename: William D
authors.initials: WD
authors.lastname: Martin
authors.forename: Anne S
authors.initials: AS
authors.lastname: De Groot
mesh_terms: D000818:Animals; D001500:BCG Vaccine / Q000235:genetics* / Q000276:immunology; D018604:Epitope Mapping; D000939:Epitopes / Q000235:genetics* / Q000276:immunology; D006801:Humans; D014376:Tuberculosis / Q000453:epidemiology / Q000276:immunology / Q000517:prevention & control*; D032581:Tuberculosis Vaccines / Q000235:genetics* / Q000276:immunology
chemical_list: D001500:BCG Vaccine; D000939:Epitopes; D032581:Tuberculosis Vaccines